{"id":"W4402107731","doi":"10.1016/j.jaad.2024.07.577","title":"52671 Bimekizumab safety and tolerability in moderate to severe plaque psoriasis: Pooled analysis from up to 4 years of treatment in 5 phase 3/3b clinical trials","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Tolerability; Plaque psoriasis; Clinical trial; Dermatology; Psoriasis; Pooled analysis; Adverse effect; Internal medicine; Meta-analysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01401189,0.002269434,0.009361345,0.001167239,0.0004501186,0.002320302,0.0009728094,0.001909717,0.003188564],"category_scores_gemma":[0.008879048,0.001122716,0.02058559,0.001519137,0.0007005986,0.001718311,0.001005776,0.002777041,0.000492462],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008290163,"about_ca_system_score_gemma":0.0009583932,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001111333,"about_ca_topic_score_gemma":0.002655166,"domain_scores_codex":[0.9937958,0.003587198,0.0006296689,0.0009602091,0.0005744015,0.0004527098],"domain_scores_gemma":[0.9932058,0.003312111,0.001924727,0.0006719792,0.0005278047,0.0003576466],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.5870293,0.000496261,0.02120199,0.01152151,0.3164746,0.0002394351,0.0001385225,0.003870771,0.003657968,0.0002005382,0.003310452,0.0518586],"study_design_scores_gemma":[0.2349613,0.04566452,0.1400301,0.001594609,0.5638454,0.0007085922,0.0002184077,0.002820836,0.001521544,0.00102517,0.007347859,0.0002616548],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6391649,0.3420329,0.00435917,0.0007577433,0.0009669678,0.001086959,0.006305771,0.0003539425,0.004971615],"genre_scores_gemma":[0.9682925,0.02391114,0.001044238,0.0009126934,0.0005924007,0.000585316,0.003393308,0.00008346421,0.001185008],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01401189,"threshold_uncertainty_score":0.07410282,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05068970887569089,"score_gpt":0.384595949770265,"score_spread":0.3339062408945741,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}